II. General
- Pulmonary Arterial Hypertension (Primary Pulmonary Hypertension) is idiopathic
- Causes below relate to Secondary Pulmonary Hypertension
III. Causes: Pulmonary Arterial Hypertension (PAH) - WHO Group 1
- Previously known as Primary Pulmonary Hypertension (PPH)
-
Genetic predisposition
- BMPR2 gene (bone morphogenetic Protein receptor type 2)
- ALK1 gene (activin receptor-like kinase type 1)
- Endoglin (with or without Hereditary Hemorrhagic Telangiectasia)
- Human Immunodeficiency Virus (HIV) Infection
- Significant liver disease with Portal Hypertension
- Collagen vascular disease (Connective Tissue Disease)
- Schistosomiasis
- Congenital disorders
- Congenital Heart Disease with systemic to pulmonary cardiac shunts (left to right shunt)
- Persistent Pulmonary Hypertension of the Newborn
- Medications
- Aminorex
- Fenfluramine
- Dexfenfluramine
- Toxic rapeseed oil
- Amphetamines
- L-Tryptophan
- Possible causes of PAH
- Human Herpes Virus 8
- Selective Serotonin Reuptake Inhibitors
- Cocaine Abuse
- Chemotherapy agents
- Pregnancy
- Systemic Hypertension
- Thyroid disease (esp. Hyperthyroidism)
- Severe Anemia
- Post-Covid Long-Term Effects
- Persistent Dyspnea may be related to pulmonary vasculopathy (microthrombi related)
- Pulmonary Hypertension may develop in 22% after ICU care of Covid19
- Unlikely causes of PAH
IV. Causes: Left Heart Conditions - WHO Group 2 (post-capillary Pulmonary Hypertension)
- Heart Failure (with or without preserved ejection fraction)
- Valvular heart disease
- Other Congenital or Acquired cardiovascular conditions causing postcapillary Pulmonary Hypertension
- Disease of the left atrium
- Disease of the left ventricle
- Central pulmonary vein compression
- Fibrosing mediastinitis
- Adenopathy
- Tumor masses
V. Causes: Respiratory (Progresses to Cor Pulmonale) - WHO Group 3
- Pulmonary parenchymal Disease
- Breathing Mechanics
- Kyphoscoliosis or Pectus Excavatum
- Neuromuscular disorder
- Obesity Hypoventilation Syndrome (marked Obesity)
- Sleep Apnea or other sleep disordered breathing
- Chronic exposure to high altitude
VI. Causes: Thrombotic or Thromboembolic - WHO Group 4
- Recurrent Pulmonary Embolus
- Sickle Cell Anemia
- Pulmonary Capillary Hemangiomatosis
VII. Causes: Miscellaneous or multifactorial - WHO Group 5
- Hematologic causes
- Myeloproliferative disorders
- Post-splenectomy
- Systemic disorders
- Sarcoidosis
- Pulmonary Langerhans Cell Histiocytosis
- Lymphangioleiomyomatosis
- Neurofibromatosis
- Vasculitis
- Metabolic disorders
- Glycogen Storage Disease
- Gaucher disease
- Thyroid disorders
- Other
- Tumoral obstruction
- Fibrosing mediastinitis
- Chronic Renal Failure on Hemodialysis
VIII. References
- Rounds (April 1998) Consultant 797-819
- Abenhaim (1996) N Engl J Med 335:609-16 [PubMed]
- Chaouat (1996) Chest 109:380-6 [PubMed]
- Dunlap (2016) Am Fam Physician 94(6):463-9 [PubMed]
- Galie (2009) Eur Heart J 30(20): 2493-537 [PubMed]
- Mesa (1998) Mayo Clin Proc 73:37-45 [PubMed]
- Moser (1990) Circulation 81:1735-43 [PubMed]
- Simonneau (1998) Chest 114:195S-9S [PubMed]
IX. Resources
- World Symposium on Primary Pulmonary Hypertension